BioCryst to Report Third Quarter 2025 Financial Results on November 3

Rhea-AI Summary

BioCryst (Nasdaq: BCRX) will report third quarter 2025 financial results on Monday, November 3, 2025. Management will host a conference call and live webcast at 8:30 a.m. ET to discuss results and provide a corporate update.

Dial-in numbers are 1-844-481-2942 (U.S.) and 1-412-317-1866 (international). A live webcast and replay will be available in the investors section of the company website at www.biocryst.com.

News Market Reaction – BCRX

+4.52%

+4.52% Session close to close

In the Oct 20 session, BCRX gained 4.52%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2025 financial results on Monday, November 3, 2025.

BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.

The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO^® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
Investors:
investorrelations@biocryst.com

Media:
media@biocryst.com

FAQ

When will BioCryst (BCRX) report third quarter 2025 results?

BioCryst will report Q3 2025 financial results on Monday, November 3, 2025.

What time is the BioCryst (BCRX) Q3 2025 conference call and webcast?

The company will host the conference call and live webcast at 8:30 a.m. ET on November 3, 2025.

How can investors join the BioCryst (BCRX) earnings call on November 3, 2025?

Domestic callers can dial 1-844-481-2942; international callers can dial 1-412-317-1866.

Where can I watch the BioCryst (BCRX) webcast and access the replay for Q3 2025?

The live webcast and replay will be available in the investors section of the company website at www.biocryst.com.

Will BioCryst (BCRX) provide a corporate update during the Q3 2025 call?

Yes, management will discuss financial results and provide a corporate update during the call on November 3, 2025.